NDC 68788-0848

SennaLax-S

Senna And Docusate Sodium

SennaLax-S is a Oral Tablet, Film Coated in the Human Otc Drug category. It is labeled and distributed by Preferred Pharmaceuticals Inc.. The primary component is Docusate Sodium; Sennosides.

• Product ID: 68788-0848_a88302d8-3c08-408e-9dc7-abc5798037c0
• NDC: 68788-0848
• Product Type: Human Otc Drug
• Proprietary Name: SennaLax-S
• Generic Name: Senna And Docusate Sodium
• Dosage Form: Tablet, Film Coated
• Route of Administration: ORAL
• Marketing Start Date: 2018-02-15
• Marketing Category: OTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL
• Application Number: part334
• Labeler Name: Preferred Pharmaceuticals Inc.
• Substance Name: DOCUSATE SODIUM; SENNOSIDES
• Active Ingredient Strength: 50 mg/1; mg/1
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 68788-0848-1

100 TABLET, FILM COATED in 1 BOTTLE (68788-0848-1)

• Marketing Start Date: 2018-02-15
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 68788-0848-1 [68788084801]

SennaLax-S TABLET, FILM COATED

• Marketing Category: OTC monograph not final
• Application Number: part334
• Product Type: HUMAN OTC DRUG
• Marketing Start Date: 2018-02-15

Drug Details

Active Ingredients

Ingredient	Strength
DOCUSATE SODIUM	50 mg/1

OpenFDA Data

• SPL SET ID: a461dfa0-5349-4e5e-aaf3-43c9446b991c
• Manufacturer:
  • Preferred Pharmaceuticals Inc.
• UNII:
  • F05Q2T2JA0
  • 3FYP5M0IJX
• RxNorm Concept Unique ID - RxCUI:
  • 998740

NDC Crossover Matching brand name "SennaLax-S" or generic name "Senna And Docusate Sodium"

NDC	Brand Name	Generic Name
0603-0283	SennaLax-S	senna and docusate sodium
55700-365	SennaLax-S	senna and docusate sodium
68788-0848	SennaLax-S	senna and docusate sodium
0603-0149	DocQLax	senna and docusate sodium
11534-090	Senna and Docusate Sodium	Senna and Docusate Sodium
11534-134	Senna and Docusate Sodium	Senna and Docusate Sodium